Trademark: 97132237
Word
K
Status
Pending
Status Code
730
Status Date
Tuesday, December 19, 2023
Serial Number
97132237
Mark Type
3000
Filing Date
Thursday, November 18, 2021
Published for Opposition
Tuesday, May 2, 2023

Trademark Owner History
Purdue Pharma L.P. - Owner At Publication

Classifications
5 A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists
42 Pharmaceutical research and development
The mark consists of a stylized letter K.
Color is not claimed as a feature of the mark.

Trademark Events
Dec 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2023
Sou Extension 1 Granted
Dec 19, 2023
Sou Extension 1 Filed
Dec 19, 2023
Sou Teas Extension Received
Jun 27, 2023
Noa E-Mailed - Sou Required From Applicant
May 2, 2023
Official Gazette Publication Confirmation E-Mailed
May 2, 2023
Published For Opposition
Apr 12, 2023
Notification Of Notice Of Publication E-Mailed
Mar 27, 2023
Approved For Pub - Principal Register
Mar 16, 2023
Examiner's Amendment Entered
Mar 16, 2023
Notification Of Examiners Amendment E-Mailed
Mar 16, 2023
Examiners Amendment E-Mailed
Mar 16, 2023
Examiners Amendment -Written
Mar 7, 2023
Previous Allowance Count Withdrawn
Dec 27, 2022
Withdrawn From Pub - Og Review Query
Dec 14, 2022
Approved For Pub - Principal Register
Dec 7, 2022
Teas/Email Correspondence Entered
Dec 7, 2022
Correspondence Received In Law Office
Dec 7, 2022
Teas Response To Office Action Received
Jun 14, 2022
Notification Of Priority Action E-Mailed
Jun 14, 2022
Priority Action E-Mailed
Jun 14, 2022
Priority Action Written
Jun 7, 2022
Assigned To Examiner
Nov 24, 2021
Notice Of Design Search Code E-Mailed
Nov 23, 2021
New Application Office Supplied Data Entered
Nov 22, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24